Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer - Saridogan, Turcin; Akcakanat, Argun; Zhao, Ming; Evans, Kurt W.; Yuca, Erkan; Scott, Stephen; Kirby, Bryce P.; Zheng, Xiaofeng; Ha, Min Jin; Chen, Huiqin; Ng, Patrick K. S.; DiPeri, Timothy P.; et al. (Scientific reports, 2023)
Keywords: 631/208/69; 692/4028/67/1059; 692/4028/67/1347; Animals; Antitumor activity; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Disease Models, Animal; Female; Fibroblast growth factor receptor 1; Fibroblast growth factor receptor 2; Fibroblast growth factor receptors; Fibroblasts; Gene expression; Growth factors; Humanities and Social Sciences; Humans; multidisciplinary; Pyrazoles; Pyrimidines - pharmacology; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1 - genetics; Receptor, Fibroblast Growth Factor, Type 2 - metabolism; Receptors, Fibroblast Growth Factor - metabolism; Science; Science (multidisciplinary); Therapeutic targets; Tumors